glioma
Conditions
Interventions
None listed
Sponsors
Osaka Medical and Pharmaceutical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients who were histologically or clinically diagnosed as glioma after 2000
Exclusion criteria
Exclusion criteria: Patients who was suspected, but not diagnosed as glioma Patients whose clinical data was lost
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| survival time | — |
Secondary
| Measure | Time frame |
|---|---|
| objective response rate progression-free survival | — |
Countries
Japan
Contacts
Public ContactMotomasa Furuse
Osaka Medical and Pharmaceutical University Department of Neurosurgery
Outcome results
None listed